Jaren Arbanas

Statistics

Publications

Citations

183

H-Index

Active since

2016

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Sweden)

Jaren Arbanas is an author at Bristol-Myers Squibb (United States) specializing in antibody glycosylation effects, immune regulation by regulatory t cells, and molecular pharmaceutics.

ORCID

Publications per year

2016–2022

Publications

IL-2/CD25: A Long-Acting Fusion Protein That Promotes Immune Tolerance by Selectively Targeting the IL-2 Receptor on Regulatory T Cells

Natasha C. Ward, Aixin Yu, Alejandro Moro et al. · The Journal of Immunology · 2018 · 102 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Dissecting Therapeutic Resistance to ERK Inhibition

Sharda Jha, Erick J. Morris, Alan Hruza et al. · Molecular Cancer Therapeutics · 2016 · 53 citations · Full text

Medicine, Oncology, Pharmacology +14

Impact of Drug Conjugation on Thermal and Metabolic Stabilities of Aglycosylated and <i>N</i>-Glycosylated Antibodies

Sayumi Yamazoe, Srikanth Kotapati, Jason M. Hogan et al. · Bioconjugate Chemistry · 2022 · 18 citations · Full text

Pharmacy, Biochemistry, Molecular Pharmaceutics +17

Characterization of Mauritian Cynomolgus Macaque FcγR Alleles Using Long-Read Sequencing

Amelia K. Haj, Jaren Arbanas, Aaron P. Yamniuk et al. · The Journal of Immunology · 2018 · 10 citations · Full text

Life Sciences, Genetics, Immunology +17

1–4 of 4